| Literature DB >> 30133688 |
Maria Aparecida Shikanai-Yasuda1, Rinaldo Pôncio Mendes2, Arnaldo Lopes Colombo3, Flávio de Queiroz Telles4, Adriana Kono5, Anamaria Mello Miranda Paniago6, André Nathan5, Antonio Carlos Francisconi do Valle7, Eduardo Bagagli8, Gil Benard1, Marcelo Simão Ferreira9, Marcus de Melo Teixeira10, Mario Leon Silva Vergara11, Ricardo Mendes Pereira12, Ricardo de Souza Cavalcante2, Rosane Hahn13, Rui Rafael Durlacher14, Zarifa Khoury15, Zoilo Pires de Camargo3, Maria Luiza Moretti1, Roberto Martinez16.
Abstract
Paracoccidioidomycosis is a systemic fungal disease associated with agricultural activities. Its incidence and prevalence are underestimated because of the lack of reporting in several Brazilian states. If paracoccidiodomycosis is not diagnosed and treated early and adequately, endemic fungal infection may result in serious sequelae. In addition to the Paracoccidioides brasiliensis (P. brasiliensis) complex, the appearance of a new species, Paracoccidioides lutzii (P. lutzii), in Rondônia state, where the disease has reached epidemic levels, and in the country's Midwest region and Pará state, are challenges to diagnosis and to the urgent availability of antigens that are reactive with patients' sera. These guidelines aim to update the first Brazilian consensus on paracoccidioidomycosis by providing evidence-based recommendations for bedside patient management. The guidelines provide data on etiology, epidemiology, immunopathogenesis, diagnosis, treatment and sequelae, with emphasis on diagnosis and treatment, as well as current recommendations and challenges in this field of knowledge.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30133688 DOI: 10.5123/S1679-49742018000500001
Source DB: PubMed Journal: Epidemiol Serv Saude ISSN: 1679-4974